Search company, investor...
NanoInk company logo


Founded Year



Dead | Dead

Total Raised


About NanoInk

NanoInk, Inc. is a technology company engaged in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using Dip Pen Nanolithography (DPN), a patented and nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. NanoInk's technique aims to bring sophisticated nanofabrication to the laboratory desktop.

Headquarters Location

8025 Lamon Avenue

Skokie, Illinois, 60077,

United States


Missing: NanoInk's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NanoInk's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing NanoInk

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

NanoInk is included in 1 Expert Collection, including Advanced Materials.


Advanced Materials

1,277 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

NanoInk Patents

NanoInk has filed 17 patents.

patents chart

Application Date

Grant Date


Related Topics




Scanning probe microscopy, Nanotechnology, Lithography (microfabrication), Physical oceanography, Microscopy


Application Date


Grant Date



Related Topics

Scanning probe microscopy, Nanotechnology, Lithography (microfabrication), Physical oceanography, Microscopy



Latest NanoInk News

Quantum Group Significantly Expands Capabilities with the Purchase of a Landa S10P Nanographic Printing® Press

Aug 9, 2022

News provided by Share this article Share this article MORTON GROVE, Ill., Aug. 8, 2022 /PRNewswire/ --Quantum Group, a trusted expert in direct marketing and business communications services has made a major investment in marketing on demand with the purchase of a Landa S10P Nanographic Printing Press. The press, which complements Quantum's extensive line of digital and offset equipment, will be installed by the end of the year and will enable Quantum to meet increased customer demand. The company, supporting customers in industries such as pharmaceuticals, healthcare, retail, insurance, and more, is seeing a 5-fold growth in personalized mailings since 2018. Along with the equipment investment, Quantum increased its manufacturing footprint by 50% to support this exponential growth. Landa S10P Nanographic Printing Press "We are excited to add the Landa S10P to our production fleet," said Cheryl Kahanec, Quantum Group's, Chief Executive Officer. "Our customers will be able to more effectively and efficiently communicate to their audiences. With the format size, substrate range, speed and quality, the Landa will expand our current offset and digital platform to ensure successful execution of timely and targeted projects. We look forward to empowering our clients with efficiency, flexibility and quality all while offering increased personalization and decreased speed to market." The Landa S10P Nanographic Printing Press is a B1-format (41 in. /1,050 mm) digital press that powers the printing of jobs in collated order and can produce high-quality prints on any off-the-shelf substrate, from 2.4 to 24pt — with no pretreatment required. The Landa S10P offers the ultimate in efficient production, printing 6,500 single-sided sheets per hour and 3,250 double-sided sheets per hour. In addition to its high speeds, the press also offers the industry's broadest color gamut, covering 96% of Pantone colors. What's more, the technology behind Landa NanoInk® enables precise, efficient low ink lay-down, which produces extremely round dots with super-sharp edges, high optical uniformity, and consistent density. This means that NanoInk on paper is just .5 microns thick, less than half the thickness of offset ink images. Plus, NanoInk colorants are supplied as concentrates and are mixed with water onsite, which avoids unnecessary shipping of water, saving space and weight and reducing the impact on our planet. "We believe the future is bright for both Quantum and our customers," said Kahanec. "Our customers know we excel at executing personalized communications that help them connect with their target audiences, and our latest technology investment will help us continue to exceed their expectations." About Landa Digital Printing Landa Digital Printing™ liberates printers from barriers inherent to traditional digital and conventional analog printing. Landa Nanographic Printing Presses produce stunning images of unbeatable color range, of any run length, on any coated or uncoated paper, and in the fastest turnaround times, thanks to its unique technology: Nanography®. Landa Digital Printing is owned by its majority shareholder, Benny Landa; and ALTANA and SKion, both wholly owned by German entrepreneur Susanne Klatten. Learn more at . About Quantum Group Quantum Group is a technology-enabled production firm specializing in high-quality digital and offset print and integrated communications services that offers sophisticated capabilities and exceptional customer service. Founded in 1992 as a high-quality commercial sheet-fed printer, Quantum has evolved into a single-source, customer-centric communications partner. Quantum is compliant with FISMA, HIPAA, and SOC 2 standards, reflecting a commitment to safeguarding data throughout the communications process. Learn more at . Contact

NanoInk Frequently Asked Questions (FAQ)

  • When was NanoInk founded?

    NanoInk was founded in 2001.

  • Where is NanoInk's headquarters?

    NanoInk's headquarters is located at 8025 Lamon Avenue, Skokie.

  • What is NanoInk's latest funding round?

    NanoInk's latest funding round is Dead.

  • How much did NanoInk raise?

    NanoInk raised a total of $74M.

  • Who are the investors of NanoInk?

    Investors of NanoInk include Lurie Investment Fund, Galway Partners, Fitzsimons Colorado Science and Technology Park and Illinois Partners.

  • Who are NanoInk's competitors?

    Competitors of NanoInk include Nanosys, OcuNexus Therapeutics, Histogenics, Regentis Biomaterials, Juventas Therapeutics and 13 more.

Compare NanoInk to Competitors


Nanotope is a regenerative medicine company that leverages a core set of technologies to address multiple therapeutic markets. Nanotope is developing a suite of products, each customized to regenerate specific tissues; including neuronal, vascular, bone, myocardial, and cartilage. The products are injectable compounds that work with surviving cells in and around the point of damage to initiate and support tissue regeneration and growth. Once regeneration is complete, the compounds are safely broken down and removed by the body. Nanotope's lead products target neuron regeneration for prevention or reversal of paralysis associated with spinal cord injury and angiogenesis for wound healing and the treatment of peripheral artery disease.n


Biofisica develops and markets products for soft tissue wound healing and tissue regeneration based on an exclusive and technology that uses electrical stimulation and hydro-gel materials.

Nimura Genetic Solutions

Isolating diverse creatures including species indegenous to rainforests in Malaysia, exploring new compounds which lead development of new medicine conforming to CBD and building a predominant bio-resource collection, NGS will contribute to health and progress of bioindustries in international community.


CartiCure is a MedTech company for tissue engineering; developing innovating technology for cartilage repair. CartiCure's technological platform generates original hyaline cartilage-producing cells to be transplanted into damaged joints; efficiently replenishing small and large lesions in the articular cartilage.nCarticure was established in 2005 and is currently based on the premises of the NGT High-Tech Incubator in Nazareth, Israel; all scientific work as well as on-going animal trials are being conducted at the Faculty of Medicine at Technion-Israel Institute of Technology in Haifa, Israel.

FirstString Research

FirstString is a biopharmaceutical company dedicated to discovering therapies for inflammation-based medical conditions.

OcuNexus Therapeutics

OcuNexus Therapeutics is a development stage biopharmaceutical company that develops treatments for front- and back-of-the-eye diseases and disorders.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.